Arrowhead Publishers

Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis and forecasting that is essential in today’s ultra-competitive pharmaceutical and biotech markets.

Arrowhead analysts draw upon the most up-to-date information and lend their industry expertise to market reports which assess the state of burgeoning pharmaceutical and biotech markets.

Our reports not only provide the most up-to-date market figures, forecasts, and pipeline data, but offer valuable analysis regarding successes and failures in the ever-competitive healthcare industry.

Arrowhead reports blend information and analysis concerning clinical trials, industry trends, and market dynamics to come to determinations about the future of of the pharmaceutical and biotech industries.

Our market reports are designed with the time-sensitive executive in mind and include a large number of graphs and tables which illustrate trends and forecasts that are integral to an understanding of the global healthcare market.

Arrowhead Publishers
 

List of reports from Arrowhead Publishers

< prev 1  2  next >
The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact
1/1/2011 | published by: Arrowhead Publishers
... (CRI) and the Cancer Immunotherapy Consortium (CIC) also proposed much needed criteria to standardize vaccine clinical trials. Although the major milestones attained in the clinical development of therapeutic cancer vaccines has brought hope and guidance ...  |  more...
$2,750.00
Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
5/1/2010 | published by: Arrowhead Publishers
... this paradigm promise to improve an individual’s treatment outcome and reduce healthcare expenditure, personalized medicine is set to transform the pharmaceutical/biotechnology and companion diagnostic markets. Arrowhead’s Personalized Medicine 2010 report provides an in-depth assessment of ...  |  more...
$2,495.00
Lung Cancer Therapeutics Market Outlook and Pipeline Analysis
11/1/2009 | published by: Arrowhead Publishers
... a vital role in the management of lung cancer. Such high level of unmet need ensures the lung cancer market is an attractive commercial opportunity for new drug development. Lung Cancer Therapeutics Market & Pipeline ...  |  more...
$2,495.00
The Rheumatoid Arthritis Market Competitive Landscape and Clinical Stage Analysis
5/26/2009 | published by: Arrowhead Publishers
... within five years of diagnosis, which means that the indirect costs associated with this disease can be very high. While the prevalence of rheumatoid arthritis has decreased in recent years, partly due to stricter diagnosing ...  |  more...
$1,495.00
Cancer Therapeutics: Market Insight & Pipeline Analysis
8/21/2008 | published by: Arrowhead Publishers
... cancer, prostate cancer, lung cancer, breast cancer, leukemia and non-Hodgkin’s lymphoma. Therapies for other types of cancer are discussed throughout the report, but are limited to the Company Briefs chapter and various tables throughout the ...  |  more...
$3,500.00
Evidence-Based Medicine: Current Use and Future Impact on Global Clinical and Reimbursement Practices
5/19/2008 | published by: Arrowhead Publishers
... cover a wide variety of recommendations and guidelines, as well as the basis for decisions regarding pharmaceutical reimbursement. This one-of-a-kind report discusses evidence-based medicine in a variety of its guises, illustrating the pervasive nature of ...  |  more...
$2,999.00
The Global Pain Therapeutics Market Market Analysis, R&D Pipelines and Competitive Landscape
10/29/2007 | published by: Arrowhead Publishers
... people with chronic pain are less able or unable to exercise, sleep normally, perform household chores, attend social activities, drive a car, or walk. The value of the pharmaceutical market for pain relief in 2007 ...  |  more...
$2,999.00
The Global Antibacterials Market: R&D Pipelines, Market Analysis and Competitive Landscape
8/28/2007 | published by: Arrowhead Publishers
... the uptake of newer antibacterial agents such as glycopeptides and carbapenems which demonstrate resistance to methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) as well as other emerging strains. Pharmaceutical companies continue to develop a ...  |  more...
$2,499.00
The Global Antivirals Market: R&D Pipelines, Market Analysis and Competitive Landscape
5/17/2007 | published by: Arrowhead Publishers
... R&D Pipelines, Markey Analysis and Competitive Landscape, the anti-viral market will be driven by the uptake of newer anti-retroviral agents in combination therapy and the launch of ten new products for the treatment of HIV ...  |  more...
$2,499.00
Outsourcing Clinical Trials: A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index
5/1/2007 | published by: Arrowhead Publishers
... in the IT industry. The big question is: Do clinical research capabilities comparable to the US in terms of sophistication and FDA-compliance exist anywhere else in the world? And if they do, are they ready ...  |  more...
$2,999.00
Innovations and Trends in Clinical Trials: Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology
3/8/2007 | published by: Arrowhead Publishers
... rationalizing and accelerating the drug discovery process by identifying failures at an earlier stage. This report provides detailed information regarding new developments in the field of clinical trials as well as an assessment of the ...  |  more...
$2,250.00
Neurodegenerative Disorder Therapies
1/31/2007 | published by: Arrowhead Publishers
... of aged people, increased life expectancy, unmet clinical needs together with advances in treatments of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease will continue to contribute to the expansion of the global market. This ...  |  more...
$2,250.00
Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight
1/11/2007 | published by: Arrowhead Publishers
... Monoclonal antibody (MAbs) therapies have been posting the fastest growth within the protein therapeutics market. According to Arrowhead Publishers’ report Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight the value of this market is ...  |  more...
$2,250.00
The Global Protein Therapeutics Market: Market Dynamics and Pipeline Analysis
12/7/2006 | published by: Arrowhead Publishers
... Recombinant proteins are potentially advantageous in terms of higher efficacy and fewer side effects than other pharmaceutical products, as they can be more specifically targeted to the cause of the disease, rather than the treatment ...  |  more...
$3,250.00
Injectable Drug Delivery: Market Impact and Industry Trends
10/3/2006 | published by: Arrowhead Publishers
... by the rise in patient demand, healthcare and pharma cost containment, as much as by medical and technological advances. The global market for drug delivery technology is worth in excess of US$25 billion in sales. ...  |  more...
$1,750.00
Rheumatoid Arthritis: Market Trends and R&D Insights
9/20/2006 | published by: Arrowhead Publishers
... reach nearly $13 billion by 2011. Sales of both Remicade and Enbrel continue to grow, while the introduction of Humira in 2003 has been a major stimulus to the market. All three of these products ...  |  more...
$1,250.00
The Prescribing Data Restriction Program: Critical Assessment and Best Practices
9/10/2006 | published by: Arrowhead Publishers
... need to evaluate the impact of PDRP violation, mediate their PDRP compliance strategies, and revisit their existing Sales Force Effectiveness (SFE) practices. With the introduction of the PDRP, the use of physician Rx data by ...  |  more...
$1,500.00
The Global Diabetes Market: Therapeutics, Diagnostics and Complications
8/1/2006 | published by: Arrowhead Publishers
... 1995 to over US$17 billion in 2005.  Overall, anti-diabetic drugs sales are expected to grow dramatically over the next five years to over US$22 billion in 2012 as the addressable patient population continues to increase ...  |  more...
$2,499.00
Biotech in Autoimmune and Inflammatory Disease 2006, 2nd Edition
5/1/2006 | published by: Arrowhead Publishers
... with a dearth of invention, patent expirations, and increased generic competition, among other factors undermining their profits. In this environment, the importance of market access strategies, especially in terms of pricing, reimbursement and parallel trade ...  |  more...
$2,999.00
The Global Drug Delivery Market: Research Trends and Market Outlook
5/1/2006 | published by: Arrowhead Publishers
... patent expiry by providing their reformulation services to pharmaceutical companies, but also by producing their own versions of branded products with improved delivery mechanisms. Thus, post-patent expiry sales can be switched from the ethical manufacturer ...  |  more...
$1,999.00
Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006
3/1/2006 | published by: Arrowhead Publishers
... with a dearth of invention, patent expirations, and increased generic competition, among other factors undermining their profits. In this environment, the importance of market access strategies, especially in terms of pricing, reimbursement and parallel trade ...  |  more...
$1,999.00
Cancer Therapeutics 2006: Market Dynamics and R&D Trends
12/1/2005 | published by: Arrowhead Publishers
... this growth are innovative new products, line extensions for existing products, and the coming of age of the biotech industry. Arrowhead Publishers’ new report entitled Cancer Therapeutics 2006: Market Dynamics and R&D Trends examines these ...  |  more...
$2,500.00
Amgen: Profile, Patents and Pipeline
8/1/2005 | published by: Arrowhead Publishers
... the majority of revenue is based on twenty-year old technology. Can Amgen continue its amazing revenue growth? Or will it fall behind, lacking the small molecule therapeutics that are the mainstay of modern pharmaceuticals? This ...  |  more...
$499.00
US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts
7/1/2005 | published by: Arrowhead Publishers
... in value? Contrasts in regulatory systems, legislative background and market characteristics increase the difficulties for companies from one area who are trying to enter another market. US and European Prescription Generic Markets reviews these divergent ...  |  more...
$1,125.00
Pain Therapeutics 2005: Market Dynamics and Outlook
5/1/2005 | published by: Arrowhead Publishers
... from moderate to severe chronic pain worldwide and approximately 50 million Americans suffer with pain. The value of the pharmaceutical market for pain relief reflects this seeming worldwide epidemic of pain, with the overall value ...  |  more...
$1,999.00
< prev 1  2  next >
 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!